“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...
“Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us ...
GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone ...
Hosted on MSN
Alcon reaffirms $10.3B–$10.4B 2025 sales outlook as Unity VCS and new launches drive Q4 acceleration
CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity VCS] is delivering on ...
Hosted on MSN
Alcon targets 5%–7% sales growth in 2026 while expanding Unity platform and launching new IOLs
CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent innovation launches, citing ...
William Blair initiated coverage on Alcon Inc. (NYSE: ALC) on Friday with a Market Perform rating. Over the past two years, Alcon has been aggressive in driving top-line growth both internally ...
Novartis' Alcon will introduce its recently CE-marked Clareon intraocular lens with an automated delivery system at the European Society of Cataract and Refractive Surgeons Congress next week. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results